• 1
    Chediak M. Nouvelle anomalie leukocytaire de caractere constitutionel et familiel. Rev Hematol 1952; 7:3627.
  • 2
    Higashi O. Congenital gigantism of peroxidase granules. Tohoku J Exp Med 1954; 59:31532.
  • 3
    Roder JC, Haliotis T, Klein M et al. A new immunodeficiency disorder in humans involving NK cells. Nature 1980; 284:5535.
  • 4
    Jones KL, Stewart RM, Fowler M, Fukuda M, Holcombe RF. Chediak–Higashi lymphoblastoid cell lines: granule characteristics and expression of lysosome-associated membrane proteins. Clin Immunol Immunopathol 1992; 65:21926.
  • 5
    Perou CM, Moore KJ, Nagle DL et al. Identification of the murine beige gene by YAC complementation and positional cloning. Nat Genet 1996; 13:3038.
  • 6
    Nagle DL, Karim MA, Woolf EA et al. Identification and mutation analysis of the complete gene for Chediak–Higashi syndrome. Nat Genet 1996; 14:30711.
  • 7
    Barbosa MDFS, Nguyen QA, Tchernev VT et al. Identification of the homologous beige and Chediak–Higashi syndrome genes. Nature 1996; 382:2625.
  • 8
    Barrat FJ, Auloge L, Pastural E et al. Genetic and physical mapping of the Chediak–Higashi syndrome on chromosome 1q42–43. Am J Hum Genet 1996; 59:62532.
  • 9
    Certain S, Barrat F, Pastural E et al. Protein truncation test of LYST reveals heterogenous mutation in patients with Chediak–Higashi syndrome. Blood 2000; 95:97983.
  • 10
    Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science 1984; 225:136570.
  • 11
    Kraft AS & Anderson WB. Phorbol esters increase the amount of Ca22r, phospholipid-dependent protein kinase associated with plasma membrane. Nature 1983; 301:6213.
  • 12
    Ito M, Tanabe F, Sato A, Ishida E, Takami Y, Shigeta S. Possible involvement of microfilaments in protein kinase C translocation. Biochem Biophys Res Commun 1989; 160:13449.
  • 13
    Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233:30512.
  • 14
    Ito M, Sato A, Tanabe F, Ishida E, Takami Y, Shigeta S. The thiol proteinase inhibitors improve the abnormal rapid down-regulation of protein kinase C and the impaired natural killer cell activity in (Chediak–Higashi syndrome) beige mouse. Biochem Biophys Res Commun 1989; 160:43340.
  • 15
    Ito M, Tanabe F, Takami Y, Sato A, Shigeta S. Rapid down-regulation of protein kinase C in (Chediak–Higashi syndrome) beige mouse by phorbol ester. Biochem Biophys Res Commun 1988; 153:64856.
  • 16
    Tanabe F, Cui S-H, Ito M. Abnormal down-regulation of PKC is responsible for giant granule formation in fibroblasts from CHS (beige) mice − a thiol proteinase inhibitor, E-64-d, prevents giant granule formation in beige fibroblasts. J Leukoc Biol 2000; 67:74955.
  • 17
    Okazaki T, Bell RM, Hannun YA. Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J Biol Chem 1989; 264:1907680.
  • 18
    Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science 1993; 259:176971.
  • 19
    Tanabe F, Cui S-H, Ito M. Ceramide promotes calpain-mediated proteolysis of protein kinase Cβ in murine polymorphonuclear leukocytes. Biochem Biophys Res Commun 1998; 242:12933.DOI: 10.1006/bbrc.1997.7934
  • 20
    Kanfer JN, Blume RS, Yankee RA, Wolff SM. Alteration of sphingolipid metabolism in leukocytes from patients with the Chediak–Higashi syndrome. N Engl J Med 1968; 279:4103.
  • 21
    Sato A, Tanabe F, Ito M, Ishida E, Shigeta S. Thiol proteinase inhibitors reverse the increased protein kinase C down-regulation and concanavalin A cap formation in polymorphonuclear leukocytes from Chediak–Higashi syndrome (beige) mouse. J Leukocyte Biol 1990; 48:37781.
  • 22
    Tamai M, Matsumoto K, Omura S, Koyama I, Ozawa Y, Hanada K. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. J Pharmacobio-Dyn 1986; 9:6727.
  • 23
    Barret AJ. Leukocyte elastase. Meth Enzymol 1981; 80:5818.
  • 24
    Barret AJ. Cathepsin G. Meth Enzymol 1981; 80:56188.
  • 25
    Brandt EJ, Elliott RW, Swank RT. Defective lysosomal enzyme secretion in kidneys of Chediak–Higashi (beige) mice. J Cell Biol 1975; 67:77488.
  • 26
    Kojima K, Kinoshita H, Kato T, Nagatsu T, Takada K, Sakakibara S. A new and highly sensitive fluorescence assay for collagenase-like peptidase activity. Anal Biochem 1979; 100:4350.
  • 27
    Jones MJ & Murray AW. Evidence that ceramide selectively inhibits protein kinase Cα translocation and modulates bradykinin activation of phospholipase D. J Biol Chem 1995; 270:500713.DOI: 10.1074/jbc.270.10.5007
  • 28
    Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 1994; 78:100515.
  • 29
    Suzuki K. Reaction of calcium-activated protease (CANP) with an epoxysuccinyl derivative (E64c) and iodoacetic acid. J Biochem 1983; 93:130512.
  • 30
    Tsubuki S, Saito Y, Tomioka M et al. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem 1996; 119:5726.
  • 31
    Herbert J, Augerean J, Maffrand J. Chelerythrin is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990; 172:9939.
  • 32
    Vassalli JD, Granelli-Piperno A, Griscelli G, Reich E. Specific protease deficiency in polymorphonuclear leukocytes of Chediak–Higashi syndrome and beige mice. J Exp Med 1978; 22:128590.
  • 33
    Takeuchi K, Wood H, Swank RT. Lysosomal elastase and cathepsin G in beige mice: neutrophils of beige (Chediak–Higashi) mice selectively lack lysosomal elastase and cathepsin G. J Exp Med 1986; 163:65677.
  • 34
    Bourguignon LY & Bourguignon GJ. Capping and the cytoskeleton. Int Rev Cytolbo 1984; 87:195224.
  • 35
    Oliver JM, Zurier RB, Berlin RD. Concanavalin A cap formation on polymorphonuclear leukocytes of normal and beige (Chediak–Higashi) mice. Nature 1975; 253:4713.
  • 36
    Oliver JM. Cell biology of leukocyte abnormalities − membrane and cytoskeletal function in normal and defective cells. Am J Pathol 1978; 93:22159.
  • 37
    Katz P, Roder JC, Zaytoun AM. Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak–Higashi syndrome with inducers of intracellular cyclic GMP. J Immunol 1982; 129:297302.
  • 38
    Boxer LA, Allen JM, Watanabe AM, Besch HR Jr, Baehner RL. Role of microtubules in granulocyte adherence. Blood 1978; 51:104550.
  • 39
    Lindmark A, Gullberg U, Olsson J. Processing and intracellular transport of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U937 − modulation by brefeldin A, ammonium chloride, and monensin. J Leukoc Biol 1994; 55:507.
  • 40
    Cavarra E, Martorana PA, Cortese S, Cambelli F, Simplicio PD, Lungarella G. Neutrophils in beige mice secrete normal amounts of cathepsin G and a 46 kD latent form of elastase that can be activated extracellularly by proteolytic activity. Biol Chem 1997; 378:41723.
  • 41
    Faigle W, Rapso G, Tenza D et al. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak–Higashi syndrome. J Cell Biol 1998; 141:112134. ee.